Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
Menlo Park biotech applying a data and analytics platform plus diagnostic testing to multiple sclerosis and neurodegenerative care.
0 investors
0 investors
Octiva Healthcare provides white-labeled, U.S.-based clinical support and telemedicine services—including after-hours, weekend, and holiday patient coverage—for FQHCs, community health centers, primary care clinics, and home health agencies. Its service model centers on clinically led workflows, escalation discipline, and continuity of care delivered under partner brands.
0 investors
OcuDyne develops an investigational ophthalmic device called OPTiC that is currently undergoing clinical trials in the United States. The company operates in the medical device and healthcare sector, focused on eye care applications.
0 investors
Ocugenix is a biotechnology company developing ophthalmology therapeutics based on NIH-funded research into the molecular mechanisms of wound healing and cellular response, originating from a research team at the University of Pittsburgh Medical Center. Its focus areas include eye diseases such as glaucoma and retinal conditions.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Oisín Biotechnologies develops non-viral genetic therapies built on its Fusogenix Proteo-Lipid Vehicle (PLV) delivery platform, which delivers DNA and RNA payloads to tissues throughout the body and allows repeat dosing. Its pipeline targets the biology of aging, with programs in targeted fat removal, muscle building, and longevity biology across aesthetic and longevity medicine.
0 investors
0 investors
A radiation oncology center offering proton therapy for cancer patients of all ages and diagnoses, with a clinical team of physicians and supporting staff. It participates in national clinical trials as part of its cancer treatment services.
0 investors
Okogen is a clinical-stage ophthalmic pharmaceutical company developing a treatment for acute infectious conjunctivitis, covering both bacterial and viral forms. Its lead product is in clinical trials as a single treatment for all forms of the condition.
0 investors
0 investors
0 investors
0 investors
0 investors
Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
0 investors
0 investors